29 Jan LabMD Winds Down Operations – Press Release

JANUARY 28, 2014





CONTACT NAME: Elaine Smith Marshall, Empowered PR, 562-498-8450


Mike-profile-pic2(Atlanta, GA)  Citing the debilitating effects of the Federal Trade Commission’s (FTC) investigative practices and litigation, President and CEO Michael J. Daugherty announces that he has been forced to wind down operations at his Atlanta, GA, medical facility, LabMD.


The effects of this action will be felt throughout the medical community, from LabMD’s employees to the physicians and their patients who utilize the facility. Daugherty laments that LabMD will be hampered in its mission to offer the excellent medical care and reliable diagnoses it has provided to its clients for almost 20 years.


LabMD’s wind down is largely due to the FTC’s abuse of power. Following a four year investigation of LabMD, the FTC filed an administrative suit alleging LabMD’s patient information data security was an “unfair” trade practice. Absent any established or uniform data security standards; absent Congressional approval to regulate data security practices; absent a consumer victim from any alleged LabMD security breach; all without alleging that LabMD violated HIPAA privacy regulations, the FTC has spent untold taxpayer dollars investigating LabMD, destroying jobs and usurping power over patient information from the U.S. Department of Health and Human Services. That is why on November 15, 2013, Cause of Action, a government accountability group, sued the FTC on behalf of LabMD in an effort to put an end to the agency’s arbitrary and egregious use of authority in the administrative suit.


Government Health IT has stated that this is “…a dispute that could shape the future of health privacy regulation.”


Opening in 1996, LabMD specializes in analysis and diagnosis of blood, urine, and tissue specimens for cancers, micro-organisms and tumor markers. As part of the wind down, LabMD has stopped accepting new specimens for analysis; however, it will continue to meet the needs of its current clients.


Mr. Daugherty wishes to thank LabMD’s employees for their steadfast loyalty and for providing excellent professional service to over 750,000 patients, always keeping the lab’s important work at the forefront, even under the duress of the past four years of the FTC’s intrusive and damaging practices.


Michael J. Daugherty is President and CEO of LabMD and author of The Devil Inside the Beltway: The Shocking Exposé of the U.S. Government’s Surveillance and Overreach into Cybersecurity, Medicine and Small Business.

To download a copy of this document, click HERE.

Read More

28 Jan Michael J. Daugherty talks at the Heritage Foundation

Screen shot 2014-01-28 at 6.50.24 AM

The Shocking Exposé of the U.S. Government’s Surveillance and Overreach Into Cybersecurity, Medicine and Small Business

The Devil Inside the Beltway by Michael J. Daugherty

AUTHOR MICHAEL J. DAUGHERTY to speak about his book and his personal battle with the FTC.

Hosted by David Inserra, National Security and Cyber Security, Douglas and Sarah Allison Center for Foreign Policy Studies, The Heritage Foundation

Thursday, January 30, 2014 at 11:00AM, The Heritage Foundation’s Lehrman Auditorium

RSVP here or call (202) 675-1761

Complimentary copies of the book will be provided by the author and publisher and will be available to be signed. Members of the media are invited to a private on-site reception with Mr. Daugherty immediately following the presentation.

Those who cannot attend are invited to watch online at and follow the discussion on Twitter at #overreach14.


Read More

07 Nov LabMD Slams ‘Oppressive’ FTC Subpoenas in Data Breach Row

Screen shot 2013-11-07 at 7.20.51 AMLaw360, New York (November 06, 2013, 1:33 PM ET) — LabMD Inc. on Tuesday slammed the Federal Trade Commission over some three dozen third-party subpoenas it has issued in its ongoing investigation of alleged security breaches at the cancer diagnosis firm that the agency claims exposed the private medical information of thousands of consumers.

LabMD characterized the FTC’s move, which it said follows after years of discovery during which the firm has already submitted over 5,000 pages of documents since 2010, as an undermining tactic meant to harm its reputation and sap its financial resources, according to its motion for protective order filed Tuesday to an FTC administrative law judge.

The Atlanta-based company is represented by the Washington-based nonprofit Cause of Action, whose website says it “fights to protect economic opportunity when federal regulations … threaten it,” and which on Tuesday reiterated its challenge to the FTC’s authority to regulate data security practices.

“From the outset of the FTC’s investigation, the commission has exerted authority it does not have to punish a business that has done nothing wrong,” said COA Executive Director Dan Epstein.  “COA has taken up this fight because the commission is abusing its power and destroying a small business, and it must be held accountable for demonstrations such as these burdensome subpoenas.”

The group identifies itself as nonpartisan, but Epstein, who founded the group in 2011, has in the past worked for billionaire libertarian Charles G. Koch’s foundation, which has funded various economic freedom nonprofits. A COA spokeswoman on Tuesday declined to identify its donors, citing privacy concerns.

The FTC brought its suit in August over an alleged data breach when Internet security firm Tiversa Holding Corp. took  a LabMD patient information file and gave it to the FTC after LabMD turned down a business pitch by Tiversa, according to LabMD’s motion.

The FTC has claimed that that LabMD exposed the information of roughly 10,000 consumers in two instances: once when the billing information for thousands of consumers was found on a file-sharing network, and again when LabMD documents containing the private information of some 500 consumers were stolen by identity thieves, according to the agency.

LabMD, whose data security practices are regulated by the U.S. Department of Health and Human services, argues that HHS has never accused it of violating any such security requirements and that the FTC is merely retaliating for LabMD CEO Michael Daugherty’s scathing manifesto against the agency in his new book, “The Devil Inside the Beltway.”

“Nothing else explains why the FTC would issue more than 35 subpoenas at issue here,” LabMD said in its motion. “Instead of standing on the strength (or lack thereof) of its complaint, the FTC seeks to crush LabMD by using its vast resources to harass through abusive discovery tactics.”

LabMD is represented by Reed Rubinstein of Dinsmore & Shohl LLP and Michael D. Pepson of Cause of Action.

The case is In the Matter of LabMD Inc., docket number 9357, before the Federal Trade Commission.

Read More

06 Nov LabMD Files Motion for Protective Order to Quash FTC’s Burdensome and Oppressive Subpoenas

FOR IMMEDIATE RELEASEScreen shot 2013-11-06 at 8.39.52 PM

CONTACT: Kevin Schmidt, 202-499-2414


LabMD Files Motion for Protective Order to Quash FTC’s Burdensome and Oppressive Subpoenas

Already overstepping its enforcement authority, FTC issues 35 subpoenas for 23 simultaneous depositions

WASHINGTON – Cause of Action (CoA), a government accountability organization, filed a Motion for Protective Order before an Administrative Law Judge on behalf of LabMD seeking to quash 35 subpoenas served by the Federal Trade Commission (FTC) in a single day. The subpoenas are burdensome, oppressive and are consistent with the Commission’s plain goal of forcing LabMD into submission by exhausting the small Atlanta-based cancer diagnosis company’s resources.

CoA is defending LabMD against a complaint brought by the FTC based, in part, on allegations that a third party was able to obtain data from LabMD’s computers through the peer-to-peer (P2P) file sharing program LimeWire. The FTC has attacked LabMD without publishing any data-security regulations or standards and with the knowledge that LabMD’s data security practices are regulated by the Department of Health and Human Services (HHS).  HHS has never suggested that LabMD has violated any patient information data-security regulations or requirements.

In September, CoA filed pleadings challenging the FTC’s statutory authority to regulate patient information data-security practices as “unfair acts or practices” under Section 5 of the FTC Act and denying the Commission’s claim that  LabMD supposedly failed to provide reasonable and appropriate security for personal information on its computer networks.

“From the outset of the FTC’s investigation, the Commission has exerted authority it does not have to punish a business that has done nothing wrong,” said CoA Executive Director Dan Epstein.  “CoA has taken up this fight because the Commission is abusing its power and destroying a small business, and it must be held accountable for demonstrations such as these burdensome subpoenas.”

“No court has ever said that Section 5 authorizes the FTC to regulate patient information data-security practices, or any other data-security practices, for that matter,” explained CoA Senior VP of Litigation Reed Rubinstein.  “Despite the Commission’s repeated requests, Congress has refused to confer upon the FTC jurisdiction over such data-security cases.  Therefore, in an end-run around both the courts and the Congress, the Commission illegally abuses and burdens individual businesses like LabMD.”

CoA asserts in LabMD’s Motion for Protective Order that essentially, the FTC is flexing its “muscles” in retaliation for LabMD’s [public criticism]. No other reason explains why the FTC would issue 35 subpoenas to obtain information it already has. Instead of venerably standing on the strength (or lack thereof) of its Complaint, the FTC, is utilizing the vast resources at its disposal to harass LabMD and its clients. It is demanding irrelevant, costly, unnecessary, and duplicative information in an attempt to crush LabMD and its viability as a business.

The FTC’s bullying tactics include:

  • Conducting a multi-year “civil investigation” requiring LabMD to produce thousands of documents and its principals to submit to multiple examinations by government lawyers all unsupported by any concrete allegation of wrongdoing.  Complying with the FTC’s demands has cost LabMD hundreds of thousands of dollars as well as thousands of hours of management and employee time.
  • Forcing LabMD into an administrative hearing in which the Commission itself makes the “law,” prosecutes the “violations” and then determines the “verdict.”
  • Using abusive tactics that would not be tolerated by any federal court.  For example, the FTC served 35 subpoenas on third parties around the country demanding at least 23 depositions to take place simultaneously.  For LabMD to comply with the FTC’s oppressive subpoenas, LabMD would have to hire more than 23 attorneys and pay for their transportation to appear at depositions in California, Georgia, Pennsylvania and Florida, etc.

Given the FTC’s lack of jurisdiction to even bring such a data-security action against LabMD, it makes it abusive practices all the more egregious:

  • Notwithstanding the FTC’s repeated requests that Congress confer upon it the authority to regulate data-security, Congress has refused to do so.
  • In a 2000 report to Congress, Privacy Online: Fair Information Practices in the Electronic Marketplace: A Report to Congress, for example, the FTC admitted that it “lacks the authority to require firms to adopt information practice policies” and requested that Congress enact legislation providing a federal agency with the authority to regulate data security.  Notwithstanding the FTC’s pleas, Congress has not seen fit to expand the FTC’s jurisdiction.
  • The FTC cannot rely on any statutory precedent for the proposition that the FTC has authority to regulate data-security practices under Section 5 of the FTC Act.
  • Federal District Judge William Duffy recently noted, “There is significant merit to [LabMD’s] argument that Section 5 [of the Federal Trade Commission Act] does not justify an [FTC] investigation into data security practices and consumer privacy issues….”
  • Even assuming, arguendo, that the FTC did have jurisdiction over its asserted claims against LabMD because the Commission has not promulgated any rules, regulations, or other binding guidelines establishing the data-security practices with which it expects compliance, this enforcement action against LabMD violates due process requirements guaranteed and protected by the Fifth Amendment to the U.S. Constitution.

The FTC complaint can be found here, CoA’s answer on behalf of LabMD can be found here, and the Motion for Protective Order can be found here.

About Cause of Action:

Cause of Action is a non-profit, nonpartisan government accountability organization that fights to protect economic opportunity when federal regulations, spending and cronyism threaten it. For more information, visit

About LabMD:

LabMD is a cancer detection facility that specializes in analysis and diagnosis of blood, urine, and tissue specimens for cancers, micro-organisms and tumor markers. You can find out more about their battle with the FTC here.

To schedule an interview with Cause of Action’s Executive Director Dan Epstein, contact Mary Beth Hutchins, or Kevin Schmidt,



Read More
Michael Daugherty at the Chris Evert Tennis Classic

04 Oct Michael J. Daugherty to Participate in 2013 Chris Evert Celebrity Pro-Am

Come join Michael at the Chris Evert Celebrity Tennis Classic hosted at the Delray Beach Tennis Center and Boca Raton Resort and Club in Delray, Flordia this year! The Pro-Am boasts an all-star roster that includes: Chris Evert, Kristin Chenoweth, John Lovitz, Alan Thicke, Gavin Rossdale, Scott Foley and many more. All proceeds go to charity to help drug and child abuse in Florida.

The event takes place November 15 – 17, 2013. For more information, please visit

If you enjoyed reading this article, sign up for my newsletter and follow me on:

Facebook |  Twitter  |   Google+  |  Pinterest  |   LinkedIn

The Devil Inside the Beltway can be purchased:

Amazon  |   Kobo  |   B&N   

Read More